Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBITDA (2016 - 2025)

Historic EBITDA for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$781000.0.

  • Solesence's EBITDA fell 12442.15% to -$781000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6640.65%. This contributed to the annual value of $5.1 million for FY2024, which is 24472.65% up from last year.
  • Latest data reveals that Solesence reported EBITDA of -$781000.0 as of Q3 2025, which was down 12442.15% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Solesence's EBITDA ranged from a high of $3.2 million in Q3 2024 and a low of -$1.9 million during Q4 2023
  • Moreover, its 5-year median value for EBITDA was $123000.0 (2022), whereas its average is $172368.4.
  • As far as peak fluctuations go, Solesence's EBITDA surged by 125581.4% in 2021, and later crashed by 105619.05% in 2023.
  • Quarter analysis of 5 years shows Solesence's EBITDA stood at -$299000.0 in 2021, then plummeted by 519.4% to -$1.9 million in 2022, then decreased by 2.43% to -$1.9 million in 2023, then surged by 88.24% to -$223000.0 in 2024, then plummeted by 250.22% to -$781000.0 in 2025.
  • Its EBITDA stands at -$781000.0 for Q3 2025, versus $1.9 million for Q2 2025 and $256000.0 for Q1 2025.